Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Champions Oncology, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q3 2021
- Shares held
- 6.21M
- −71.8K (−1.1%) vs. Q3 2021
- Total value
- $51.7M
- −$12.4M (−19.3%) vs. Q3 2021
- New holders
- 4
- 6 more added
- Sold out
- 8
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CSBR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $36.3M |
| Q1 2026 | 25 | $33.0M |
| Q4 2025 | 27 | $39.7M |
| Q3 2025 | 27 | $36.7M |
| Q2 2025 | 30 | $42.5M |
| Q1 2025 | 34 | $51.4M |
| Q4 2024 | 25 | $49.0M |
| Q3 2024 | 22 | $28.2M |
| Q2 2024 | 23 | $29.9M |
| Q1 2024 | 25 | $27.6M |
| Q4 2023 | 23 | $31.5M |
| Q3 2023 | 29 | $35.6M |
| Q2 2023 | 28 | $37.0M |
| Q1 2023 | 30 | $23.6M |
| Q4 2022 | 29 | $27.1M |
| Q3 2022 | 32 | $46.8M |
| Q2 2022 | 32 | $49.8M |
| Q1 2022 | 30 | $50.4M |
| Q4 2021 | 31 | $51.7M |
| Q3 2021 | 35 | $64.1M |
| Q2 2021 | 38 | $68.5M |
| Q1 2021 | 45 | $81.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Champions Oncology, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Battery Management Corp. | 2,421,673 | $20.2M | 2.73% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,713,720 | $14.3M | 0.29% | 00.0% | Unchanged |
| Vanguard Group Inc | 343,133 | $2.87M | 0.00% | +15,497+4.7% | Added |
| Millrace Asset Group, Inc. | 326,136 | $2.73M | 1.59% | +2,061+0.6% | Added |
| Tocqueville Asset Management L.P. | 252,461 | $2.11M | 0.03% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 190,746 | $1.59M | 0.00% | −30,400−13.7% | Reduced |
| BlackRock Inc. | 123,446 | $1.03M | 0.00% | +1,048+0.9% | Added |
| Essex Investment Management Co LLC | 106,423 | $890.0K | 0.10% | +16,916+18.9% | Added |
| Dimensional Fund Advisors LP | 110,619 | $885.0K | 0.00% | −9,283−7.7% | Reduced |
| Overbrook Management Corp | 81,507 | $681.0K | 0.14% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 83,032 | $664.0K | 0.00% | +83,032 | New |
| ACT Capital Management, LLC | 62,500 | $523.0K | 0.38% | +4,000+6.8% | Added |
| ClariVest Asset Management LLC | 55,400 | $463.0K | 0.01% | −900−1.6% | Reduced |
| Millennium Management LLC | 54,186 | $433.0K | 0.00% | −6,225−10.3% | Reduced |
| Geode Capital Management, LLC | 47,638 | $381.0K | 0.00% | 00.0% | Unchanged |
| Aristides Capital LLC | 36,750 | $307.0K | 0.18% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 31,476 | $261.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 30,775 | $257.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 27,476 | $230.0K | 0.00% | −392−1.4% | Reduced |
| Susquehanna Fundamental Investments, LLC | 27,849 | $223.0K | 0.01% | −533−1.9% | Reduced |
| HighTower Advisors, LLC | 26,467 | $212.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 24,563 | $197.0K | 0.00% | 00.0% | Unchanged |
| Ingalls & Snyder LLC | 11,056 | $92.0K | 0.00% | 00.0% | Unchanged |
| Globeflex Capital L P | 8,549 | $68.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 7,534 | $63.0K | 0.00% | +609+8.8% | Added |
| Masso Torrence Wealth Management Inc. | 1,000 | $8.00K | 0.01% | +1,000 | New |
| UBS Group AG | 280 | $2.00K | 0.00% | +280 | New |
| Royal Bank of Canada | 100 | $1.00K | 0.00% | −25−20.0% | Reduced |
| Bank of America Corp | 147 | $1.00K | 0.00% | +147 | New |
| JPMorgan Chase & Co | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −97,903−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −30,565−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,541−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −5,894−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −818−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −713−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −45−100.0% | Sold out |